Nutex Health, Inc. (NUTX)
NASDAQ: NUTX · IEX Real-Time Price · USD
0.655
-0.007 (-1.10%)
At close: Apr 18, 2024, 4:00 PM
0.660
+0.005 (0.75%)
After-hours: Apr 18, 2024, 7:55 PM EDT

Nutex Health Stock Forecast

NUTX's stock price has decreased by -93.97% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Nutex Health stock has a target of 15, which predicts an increase of 2,189.73% from the current stock price of 0.66.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $15 $15 $15 $15
Change +2189.7% +2189.7% +2189.7% +2189.7%
* Price targets were last updated on Jan 25, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Nutex Health is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Nov '23Dec '23Jan '24Feb '24Mar '24Apr '24
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Benchmark
Benchmark
Strong Buy
Maintains
$23$15
Strong Buy Maintains $23$15 +2,189.73% Jan 25, 2024
Benchmark
Benchmark
Strong Buy
Maintains
$38$23
Strong Buy Maintains $38$23 +3,334.59% Nov 14, 2023
Benchmark
Benchmark
Strong Buy
Reiterates
$38
Strong Buy Reiterates $38 +5,624.32% Aug 29, 2023
Benchmark
Benchmark
Strong Buy
Maintains
$45$38
Strong Buy Maintains $45$38 +5,624.32% May 17, 2023
Benchmark
Benchmark
Strong Buy
Reiterates
$45
Strong Buy Reiterates $45 +6,769.18% Mar 9, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
322.52M
from 247.65M
Increased by 30.23%
Revenue Next Year
n/a
from 322.52M
EPS This Year
-0.01
from -1.05
EPS Next Year
n/a
from -0.01
Year 201920202021202220232024
Revenue
1.37M274.03M331.53M219.29M247.65M322.52M
Revenue Growth
-0.04%19,954.54%20.98%-33.85%12.93%30.23%
EPS
-29.402.703.30-10.05-1.05-0.01
EPS Growth
--22.22%---
No. Analysts -----3
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2024
High 332.0M
Avg 322.5M
Low 309.9M

Revenue Growth

Revenue Growth 2024
High
34.1%
Avg
30.2%
Low
25.1%

EPS Forecast

EPS 2024
High -0.01
Avg -0.01
Low -0.01

EPS Growth

EPS Growth 2024
High -
Avg -
Low -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.